CONMED Return on Investment 2010-2022 | CNMD

Current and historical return on investment (ROI) values for CONMED (CNMD) over the last 10 years.
CONMED ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-06-30 $0.11B $1.66B 7.25%
2022-03-31 $0.11B $1.49B 7.64%
2021-12-31 $0.11B $1.46B 7.56%
2021-09-30 $0.10B $1.46B 6.75%
2021-06-30 $0.10B $1.45B 6.91%
2021-03-31 $0.05B $1.45B 3.65%
2020-12-31 $0.05B $1.44B 3.16%
2020-09-30 $0.05B $1.44B 3.35%
2020-06-30 $0.04B $1.47B 2.79%
2020-03-31 $0.08B $1.47B 5.48%
2019-12-31 $0.08B $1.47B 5.39%
2019-09-30 $0.08B $1.48B 5.60%
2019-06-30 $0.07B $1.49B 5.32%
2019-03-31 $0.07B $1.50B 5.61%
2018-12-31 $0.07B $1.10B 6.60%
2018-09-30 $0.07B $1.10B 6.32%
2018-06-30 $0.07B $1.08B 6.43%
2018-03-31 $0.07B $1.09B 6.09%
2017-12-31 $0.05B $1.10B 4.36%
2017-09-30 $0.04B $1.08B 3.46%
2017-06-30 $0.04B $1.07B 3.56%
2017-03-31 $0.03B $1.06B 3.07%
2016-12-31 $0.04B $1.07B 3.61%
2016-09-30 $0.04B $1.07B 3.79%
2016-06-30 $0.04B $1.09B 4.13%
2016-03-31 $0.04B $1.09B 4.86%
2015-12-31 $0.05B $0.86B 6.07%
2015-09-30 $0.06B $0.84B 6.61%
2015-06-30 $0.04B $0.84B 5.05%
2015-03-31 $0.05B $0.83B 5.51%
2014-12-31 $0.05B $0.82B 6.22%
2014-09-30 $0.05B $0.84B 6.10%
2014-06-30 $0.06B $0.85B 6.99%
2014-03-31 $0.06B $0.84B 7.05%
2013-12-31 $0.06B $0.82B 6.96%
2013-09-30 $0.06B $0.82B 7.20%
2013-06-30 $0.06B $0.82B 7.93%
2013-03-31 $0.06B $0.82B 8.26%
2012-12-31 $0.07B $0.77B 8.66%
2012-09-30 $0.01B $0.77B 0.83%
2012-06-30 $0.01B $0.74B 1.17%
2012-03-31 $0.01B $0.73B 1.21%
2011-12-31 $0.01B $0.66B 1.23%
2011-09-30 $0.06B $0.62B 9.80%
2011-06-30 $0.06B $0.65B 9.19%
2011-03-31 $0.06B $0.67B 8.58%
2010-12-31 $0.06B $0.67B 7.92%
2010-09-30 $0.06B $0.75B 7.29%
2010-06-30 $0.05B $0.75B 5.96%
2010-03-31 $0.04B $0.76B 4.64%
2009-12-31 $0.03B $0.76B 3.73%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.498B $1.011B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $64.488B 18.73
McKesson (MCK) United States $49.156B 14.27
AmerisourceBergen (ABC) United States $28.202B 12.59
Laboratory Of America Holdings (LH) United States $19.282B 8.43
West Pharmaceutical Services (WST) United States $18.606B 28.33
Cardinal Health (CAH) United States $17.762B 13.40
Cooper (COO) United States $13.294B 20.80
Invacare (IVC) United States $0.028B 0.00